Guided Therapeutics, Inc.
GTHP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -92.9% | 653.8% | -84% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 28.6% | 36.7% | -523.1% | 24.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27,728.6% | -3,189.8% | -28,361.5% | -1,134.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -34,528.6% | -3,560.2% | -33,392.3% | -2,555.6% |
| EPS Diluted | -0.045 | -0.074 | -0.15 | -0.18 |
| % Growth | 38.5% | 51% | 16.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |